Prostate cancer is one of the most common cancers among males worldwide and a common cause of cancer related mortality in males. Bone metastasis from prostate cancer is common in advanced stage disease leading to major complications including severe bone pain and fractures. Here, we present a case of 79-year-old male newly diagnosed metastatic prostate cancer, with metastasis to the lungs, liver and lymph nodes, and a solitary osteolytic bone metastasis seen in bone scan. It is well known that osseous metastasis from prostate cancer is primarily sclerotic, although lytic bone metastasis is rare, but it can also be seen as in our case.
References
[1]
McDowell, S. (2024) Cancer in Men, Prostate Cancer Is for 118 Countries Globally, American Cancer Society.
[2]
Westendorf, J.J., Kahler, R.A. and Schroeder, T.M. (2004) Wnt Signaling in Osteoblasts and Bone Diseases. Gene, 341, 19-39. https://doi.org/10.1016/j.gene.2004.06.044
[3]
Wong, S.K., Mohamad, N., Giaze, T.R., Chin, K., Mohamed, N. and Ima-Nirwana, S. (2019) Prostate Cancer and Bone Metastases: The Underlying Mechanisms. International Journal of Molecular Sciences, 20, Article 2587. https://doi.org/10.3390/ijms20102587
[4]
Rabbani, S.A., Gladu, J., Harakidas, P., Jamison, B. and Goltzman, D. (1999) Over-Production of Parathyroid Hormone-Related Peptide Results in Increased Osteolytic Skeletal Metastasis by Prostate Cancer Cells in Vivo. International Journal of Cancer, 80, 257-264. https://doi.org/10.1002/(sici)1097-0215(19990118)80:2<257::aid-ijc15>3.0.co;2-3
[5]
Agheli, A., Patsiornik, Y., Chen, Y., Chaudhry, M.R., Gerber, H. and Wang, J.C. (2009) Prostate Carcinoma, Presenting with a Solitary Osteolytic Bone Lesion to the Right Hip. Radiology Case Reports, 4, 288. https://doi.org/10.2484/rcr.v4i4.288
[6]
Rajendiran, G., Green, L. and Chhabra, G. (2011) A Rare Presentation of Prostate Cancer with Diffuse Osteolytic Metastases and PSA of 7242 ng/ml. International Journal of Case Reports and Images, 2, 16-20. https://doi.org/10.5348/ijcri-2011-09-55-cr-5
[7]
Rummel, K., Benson, J. and Roller, L. (2021) Prostate Adenocarcinoma with Osteolytic Metastases: Case Report and Review of the Literature. Radiology Case Reports, 16, 3565-3568. https://doi.org/10.1016/j.radcr.2021.08.056
[8]
Cheville, J.C., Tindall, D., Boelter, C., Jenkins, R., Lohse, C.M., Pankratz, V.S., et al. (2002) Metastatic Prostate Carcinoma to Bone. Cancer, 95, 1028-1036. https://doi.org/10.1002/cncr.10788
[9]
Goode, E.A., Wang, N. and Munkley, J. (2023) Prostate Cancer Bone Metastases Biology and Clinical Management (Review). NeologyLetters, 25, Article 163.
[10]
Ceci, F., Castellucci, P., Graziani, T., Schiavina, R., Chondrogiannis, S., Bonfiglioli, R., et al. (2015) 11C-Choline PET/CT Identifies Osteoblastic and Osteolytic Lesions in Patients with Metastatic Prostate Cancer. Clinical Nuclear Medicine, 40, e265-e270. https://doi.org/10.1097/rlu.0000000000000783
[11]
Liu, D., Kuai, Y., Zhu, R., Zhou, C., Tao, Y., Han, W., et al. (2020) Prognosis of Prostate Cancer and Bone Metastasis Pattern of Patients: A Seer-Based Study and a Local Hospital Based Study from China. Scientific Reports, 10, Article No. 9104. https://doi.org/10.1038/s41598-020-64073-6
[12]
Maccauro, G., Spinelli, M.S., Mauro, S., Perisano, C., Graci, C. and Rosa, M.A. (2011) Physiopathology of Spine Metastasis. International Journal of Surgical Oncology, 2011, 1-8. https://doi.org/10.1155/2011/107969
[13]
Suva, L.J., Washam, C., Nicholas, R.W. and Griffin, R.J. (2011) Bone Metastasis: Mechanisms and Therapeutic Opportunities. Nature Reviews Endocrinology, 7, 208-218. https://doi.org/10.1038/nrendo.2010.227
